The establishment of a COVID-19 biorepository of specimens from the maternal-neonatal dyad is a critical first step to answering questions about the impact of COVID-19 infection on the pregnant patient and the developing fetus.
Read this paper to understand the unique challenges imposed by the COVID-19 pandemic while establishing the COVID-19 perinatal biorepository, and strategies used to overcome them.
Click here to read more: Rapid establishment of a COVID-19 perinatal biorepository - OpenSpecimen